Immunologic features of asymptomatic postvaccination infections with the Delta variant of SARS-CoV-2 in adults
- PMID: 35759224
- PMCID: PMC9210569
- DOI: 10.1002/iid3.670
Immunologic features of asymptomatic postvaccination infections with the Delta variant of SARS-CoV-2 in adults
Abstract
Background: Asymptomatic infections may play an important role in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) Delta variant transmissions. However, the immunologic features of asymptomatic postvaccination infections with the Delta variant of SARS-CoV-2 in adults remain to be defined.
Methods: A retrospective study involving 36 vaccinated adults infected with the SARS-CoV-2 Delta variant was performed. Their demographic and laboratory data were collected and analyzed in The First People's Hospital of Jingmen from August 4 to 20, 2021.
Results: Of the 36 adults, 6 persons had an asymptomatic infection. The severity of the SARS-CoV-2 infections was highly correlated with the doses of vaccinations (p = 0.019). The symptomatic and asymptomatic infected SARS-CoV-2 adults showed normal levels of leukocytes and lymphocytes. The C-reactive protein (CRP) and interleukin-6 (IL-6) levels were elevated in the symptomatic groups. The period between the last vaccination to the time of infection in the asymptomatic group was longer than that in the mild and moderate groups (73 vs. 61 vs. 50 days; p = 0.047). The percentage of suppressor T-cells in the asymptomatic group was the highest (32.2 ± 4.0% vs. 22.0 ± 7.2% vs. 29.3 ± 8.0%; p = 0.004). The signal-to-cutoff ratio value of total antibody against SARS-CoV-2 in the asymptomatic group was lower than that in the other two groups (383 vs. 703 vs. 1792; p < 0.001) and much lower than that in the moderate group. The multivariate ordinal logistic analysis after adjusting for gender, vaccination date, and vaccination dose indicated that CRP at Days 4-7 and 8-14, IL-6 on Days 4-7, and total antibody were risk factors for coronavirus disease 2019 severity.
Conclusions: Asymptomatic postvaccination infections with the Delta variant of SARS-CoV-2 in adults tend to infect persons vaccinated twice. The immunophenotype profile for asymptomatic postvaccination infections is less inflammatory and accompanied by relatively lower antibody titers.
Keywords: Delta variant; SARS-CoV-2; asymptomatic; breakthrough infection; immunologic features; postvaccination infections.
© 2022 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd.
Conflict of interest statement
The author declare no conflict of interest.
Similar articles
-
Postvaccination infections among staff of a tertiary care hospital after vaccination with severe acute respiratory syndrome coronavirus 2 vector and mRNA-based vaccines.Clin Microbiol Infect. 2022 Apr;28(4):596-601. doi: 10.1016/j.cmi.2021.11.023. Epub 2021 Dec 13. Clin Microbiol Infect. 2022. PMID: 34915073 Free PMC article.
-
[Clinical features of children with coronavirus disease 2019 Delta variant infection after vaccination with inactivated SARS-CoV-2 vaccine].Zhongguo Dang Dai Er Ke Za Zhi. 2022 Jul 15;24(7):742-747. doi: 10.7499/j.issn.1008-8830.2203174. Zhongguo Dang Dai Er Ke Za Zhi. 2022. PMID: 35894187 Free PMC article. Chinese.
-
Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.JAMA. 2021 Jun 22;325(24):2457-2465. doi: 10.1001/jama.2021.7152. JAMA. 2021. PMID: 33956048 Free PMC article.
-
A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant.Int J Biol Sci. 2022 Jan 1;18(2):889-900. doi: 10.7150/ijbs.68973. eCollection 2022. Int J Biol Sci. 2022. PMID: 35002532 Free PMC article.
-
Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review.BMC Infect Dis. 2023 Jun 26;23(1):432. doi: 10.1186/s12879-023-08328-3. BMC Infect Dis. 2023. PMID: 37365490 Free PMC article.
Cited by
-
Epidemiological and Genomic Analysis of Asymptomatic SARS-CoV-2 Infections during the Delta and Omicron Epidemic Waves in São Paulo City, Brazil.Viruses. 2023 Nov 3;15(11):2210. doi: 10.3390/v15112210. Viruses. 2023. PMID: 38005887 Free PMC article.
-
Construction and evaluation of a self-replicative RNA vaccine against SARS-CoV-2 using yellow fever virus replicon.PLoS One. 2022 Oct 20;17(10):e0274829. doi: 10.1371/journal.pone.0274829. eCollection 2022. PLoS One. 2022. PMID: 36264936 Free PMC article.
References
-
- Baraniuk C. Covid‐19: how effective are vaccines against the Delta variant? BMJ. 2021;374:n1960. - PubMed
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous